Innovaderm is Excited to Attend Rheumatology Congress in Washington, D.C.!

2024-10-29

Innovaderm is excited to attend the American College of Rheumatology (ACR) Convergence!

Our team will be in Washington, D.C. from November 14th to 19th to meet with you at booth #2700.

Connect with us to schedule some time with our team at the show:

Dr. Juan Ovalles, Sr. Director, Rheumatology - Board-certified rheumatologist
Dr. Eugene Uy, Medical Monitor - Rheumatologist
Janet Overvelde, Sr. Director, Project Management
Faiza Tayar, Manager, Site Selection
Jason Shuris, Chief Business Officer
Vincent Scamacca, Executive Director, Business Development

Newsletter

Join our science community with Press Forward, our quarterly newsletter. Get the latest in dermatology clinical research. Subscribe now!

Newsletter subscription resources

*By subscribing to our newsletter, you acknowledge and agree to the terms of our privacy policy.

Innovaderm Research Appoints Ina Zschocke as New Executive Vice President, European Operations and Strategy

[MONTREAL, QC, November 19th, 2024]—Innovaderm, a leading clinical research organization (CRO) specializing in dermatology and rheumatology, is pleased to announce the appointment of Ina Zschocke, as the new Executive Vice President, European Operations and Strategy. This strategic hire underscores Innovaderm’s commitment to expanding its ever-growing presence and capabilities in the European market. Ina Zschocke, PhD, […]

Innovaderm's CMO Will be Chairing the Clinical Outsourcing Group: CRO Summit!

Innovaderm is thrilled to announce that it's Chief Medical Officer, Dr. Jasmina Jankicevic, will be chairing Pharmaceutical Business Conference Group's (PBC Group) Clinical Outsourcing Group: CRO Summit on December 3rd & 4th, 2024. The Future of Clinical Research: Summit Chair Jasmina Jankicevic Weighs in on CRO Evolution - Read the interview now to learn on the changing environment for clinical […]

Innovaderm’s Prominent Role in Advancing Dermatology Research at Highlighted During Another LEO Pharma’s Late-Breaking Session at EADV Congress in Amsterdam, The Netherlands

Innovaderm’s prominent role in advancing dermatology research was highlighted once more during a late-breaking session at the European Academy of Dermatology and Venereology (EADV) on September 27th in Amsterdam. The abstract “Randomized vehicle-controlled clinical trial with the topical JAK inhibitor delgocitinib in patients with frontal fibrosing alopecia demonstrates biomarker and clinical efficacy” was authored by […]

Innovaderm is Excited to Attend Rheumatology Congress in Washington, D.C.!

Newsletter subscription resources

Other recent articles

Innovaderm Research Appoints Ina Zschocke as New Executive Vice President, European Operations and Strategy

Innovaderm's CMO Will be Chairing the Clinical Outsourcing Group: CRO Summit!

Innovaderm’s Prominent Role in Advancing Dermatology Research at Highlighted During Another LEO Pharma’s Late-Breaking Session at EADV Congress in Amsterdam, The Netherlands